Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung Cancer
Clinical trial NCT05344209 · RECRUITING
Trial details
- NCT number
- NCT05344209
- Sponsor
- Vestre Viken Hospital Trust
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2025-07-01
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.